Sr. Correspondent, Broker Research, Bangalore, India
Saqib's Feed
Dec 10, 2014
Dec 9, 2014
Dec 9, 2014
Dec 9, 2014
Dec 9, 2014
Dec 9, 2014
Dec 8, 2014
Dec 8, 2014

Cubist options unusually active before Merck deal

NEW YORK (Reuters) – Cubist Pharmaceuticals Inc options had one of their most active weeks this year last week ahead of Monday’s announcement that Merck & Co will buy Cubist for a hefty premium.

One series of trades on Thursday appears to have generated at least a 10-fold windfall profit on paper.

Dec 5, 2014
Dec 5, 2014
    • About Saqib

      "Saqib Ahmed is an options correspondent working with the Markets team in New York. He previously led the Reuters Broker Research team in Bangalore. He joined Reuters in 2009 after graduating from the Asian College of Journalism."
      Joined Reuters:
      2009
      Languages:
      English, Hindi, Bengali
    • More from Saqib

    • Contact Saqib

    • Follow Saqib